Royalty Pharma (RPRX) EBT Margin (QoQ) (2019 - 2026)
Royalty Pharma (RPRX) EBT Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Royalty Pharma | 25.78 Bn | 28.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,704.00 |
| Dec 31, 2025 | -1,568.00 |
| Sep 30, 2025 | 5,724.00 |
| Jun 30, 2025 | -6,079.00 |
| Mar 31, 2025 | 2,013.00 |
| Dec 31, 2024 | -8,647.00 |
| Sep 30, 2024 | 10,662.00 |
| Jun 30, 2024 | 3,693.00 |
| Mar 31, 2024 | -12,114.00 |
| Dec 31, 2023 | 9,762.00 |
| Sep 30, 2023 | -4,252.00 |
| Jun 30, 2023 | -915.00 |
| Mar 31, 2023 | 18,226.00 |
| Dec 31, 2022 | -14,626.00 |
| Sep 30, 2022 | -5,329.00 |
| Jun 30, 2022 | 6,893.00 |
| Mar 31, 2022 | 1,347.00 |
| Dec 31, 2021 | -2,854.00 |
| Sep 30, 2021 | -10,751.00 |
| Jun 30, 2021 | 11,763.00 |